You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Reduction of Lung Dust Burden in Pneumoconiosis by Whole-Lung Lavage

Wilt, Jeffrey L. MD; Banks, Daniel E. MD; Weissman, David N. MD; Parker, John E. MD; Vallyathan, Val PhD; Castranova, Vincent PhD; Dedhia, Harakh V. MD; Stulken, Edward MD; Ma, Joseph K.H. PhD; Ma, Jane Y.C. PhD; Cruzzaval, Jose MD; Shumaker, Jennifer BA; Childress, Charles P. MAT; Lapp, N. LeRoy MD

Journal of Occupational & Environmental Medicine:
Original Article
Abstract

Pneumoconioses are characterized as irreversible, progressive respiratory diseases. No effective therapy exists to prevent progression of these diseases. Whole-lung lavage (WLL) might limit the rate of disease progression through the removal of dust, inflammatory cells, and cytokines. We performed WLL on a 54-year-old underground miner employed as a motorman and roof bolter and a 55-year-old driller at a surface coal mine. Both demonstrated normal lung function and chest radiographs showing ILO profusion category 2 nodular interstitial changes. From Subject 1, we recovered 5.24 x 108 cells (90% macrophages) from the right lung and 3.45 x 108 cells (94% macrophages) from the left lung. WLL removed 1.82 g of mineral dust (non-coal) on the right and 1.64 g on the left. From Subject 2, we recovered 7.49 x 108 cells (46% macrophages) from the right and 9.78 x 108 cells (69% macrophages) from the left lung. WLL removed 0.40 g of mineral dust on the right and 0.53 g on the left. Proinflammatory cytokines, growth factors, and cellular enzymes were also recovered. In cases of pneumoconiosis, WLL is capable of removing relatively large quantities of dust, cells, and soluble materials from the lungs. Only long-term follow-ups of individuals with progressive dust-induced disease who receive WLL therapy in the context of a clinical trial will provide information regarding the importance of removing mineral dust and inflammatory cells from the lung.

Author Information

From the Section of Pulmonary and Critical Care Medicine, Department of Medicine (Dr Wilt, Dr Banks, Dr Weissman, Dr Dedhia, Ms Shumaker, Dr Lapp), the School of Pharmacy (Dr JKH Ma), the Department of Anesthesiology (Dr Dedhia, Dr Stulken), and the Department of Surgery (Dr Cruzzavala), West Virginia University School of Medicine, Morgantown WVa; and the National Institute for Occupational Safety and Health, Morgantown, WVa (Dr Parker, Dr Vallyathan, Dr Castranova, Dr JYC Ma) and Cincinnati, Ohio (Mr Childress).

Address correspondence to: Daniel E. Banks, MD, Section of Pulmonary and Critical Care Medicine, Department of Medicine, West Virginia University School of Medicine, Morgantown, WV 26506-9166.

© Williams & Wilkins 1996. All Rights Reserved.